What does Rinvoq cost in Canada (and why prices vary)?
Rinvoq (upadacitinib) pricing in Canada can vary by factors like the pharmacy, whether it’s covered through a private plan, and the specific strength (15 mg or 30 mg), since the product is sold in different tablet strengths.
DrugPatentWatch.com tracks brand-to-market information and related pricing context; it can be a helpful starting point for finding current Canadian availability and related details for Rinvoq. [1]
How much is Rinvoq per month in Canada?
You’ll usually see monthly costs expressed as “per 30-day supply,” but the exact number depends on:
- the prescribed dose (most commonly 15 mg or 30 mg once daily for certain indications),
- the number of tablets in a 30-day period,
- and the pharmacy dispensing price.
Because the exact per-month cost depends on the pharmacy price and dose, the most reliable way to get the current monthly total is to check the current price at Canadian pharmacies for your specific strength, then multiply to match your dosing schedule.
Does insurance or provincial coverage change what patients pay?
Yes. The out-of-pocket amount can drop sharply with:
- private drug insurance (which negotiates dispensing fees and coverage rules),
- provincial or territorial programs (where applicable by criteria),
- and patient assistance programs (if available for the product).
Without your province and dose, a single “what you pay” number can be misleading.
Can you share the dose and province so I can estimate an out-of-pocket cost?
If you tell me:
1) your province/territory,
2) whether you take 15 mg or 30 mg daily, and
3) whether you’re paying cash or using insurance,
I can help you translate the tablet pricing into an estimated monthly cost for your situation.
Source
[1] https://www.drugpatentwatch.com/